Alliance Wealth Advisors (Utah)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$428K Sell
3,636
-1,174
-24% -$164K 0.09% 150
2025
Q4
$788K Sell
4,810
-1,695
-26% -$265K 0.17% 130
2025
Q3
$870K Buy
6,505
+2,739
+73% +$333K 0.2% 131
2025
Q2
$468K Buy
3,766
+91
+2% +$11.6K 0.11% 172
2025
Q1
$468K Buy
3,675
+89
+2% +$13.7K 0.12% 164
2024
Q4
$516K Buy
3,586
+199
+6% +$28.5K 0.13% 157
2024
Q3
$504K Buy
3,387
+195
+6% +$28K 0.13% 151
2024
Q2
$402K Buy
3,192
+324
+11% +$50.8K 0.12% 164
2024
Q1
$527K Buy
2,868
+408
+17% +$77.7K 0.16% 135
2023
Q4
$442K Buy
2,460
+114
+5% +$17.7K 0.15% 147
2023
Q3
$373K Buy
2,346
+210
+10% +$34.3K 0.14% 154
2023
Q2
$302K Buy
2,136
+321
+18% +$51.5K 0.11% 173
2023
Q1
$306K Buy
1,815
+194
+12% +$34.6K 0.12% 172
2022
Q4
$274K Buy
+1,621
New +$294K 0.12% 170

Other funds holding RGEN

Alliance Wealth Advisors (Utah)'s RGEN Position: Q1 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Repligen (RGEN) stake by 24% in Q1 2026, selling an estimated $164K and leaving 3,636 shares worth $428K. The position accounts for 0.09% of the portfolio, ranked #150.

Alliance Wealth Advisors (Utah) first reported a position in RGEN in Q4 2022 and has held it in 14 quarters since. The position peaked at $870K in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Alliance Wealth Advisors (Utah) held 3,636 shares of Repligen worth $428K as of Q1 2026.
  • Alliance Wealth Advisors (Utah) sold 1,174 Repligen shares in Q1 2026, an estimated $164K.
  • Repligen made up 0.09% of Alliance Wealth Advisors (Utah)'s portfolio in Q1 2026, its #150 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Repligen in Q4 2022 and has held it in 14 quarters since.
  • Alliance Wealth Advisors (Utah)'s Repligen position peaked at $870K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q1 2026, filed 12 May 2026.